Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.69 |
| ▸ | TGM2 | P21980 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | KRAS | P01116 | 4/20 | 0.62 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.61 |
| ▸ | HINT1 | P49773 | 3/20 | 0.61 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.58 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.58 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.58 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.58 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.58 |
| ▸ | GSK3A | P49840 | 2/20 | 0.58 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.58 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL30589987 | 1.00 | NT5E (0.69) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL9827513 | 1.00 | NT5E (0.69) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL19211836 | 0.99 | NT5E (0.68) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL30125158 | 0.99 | NT5E (0.68) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL4625995 | 0.99 | NT5E (0.68) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL27797461 | 0.97 | NT5E (0.70) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL37404 | 0.97 | NT5E (0.70) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL4410882 | 0.96 | TGM2 (0.65) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL22134208 | 0.96 | NT5E (0.69) | NT5ETGM2HPGDKRASFUT5 | |
| Guanosine SCHEMBL29046528 | 0.96 | TGM2 (0.64) | NT5ETGM2HPGDKRASFUT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105973890-B | A kind of screening technique of active substance of plant | 西南大学 | 2018-11-13 | — | — | CN | claimed |
| CN-106086183-A | A kind of based on rich guanine DNA sensitization Tb3+the MicroRNA detection method of fluorescence | 南昌大学 | 2016-11-09 | — | — | CN | claimed |
| US-12600958-B2 | Methods and compositions for manufacturing polynucleotides | PRIMROSE BIO, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20230076421-A1 | METHODS AND COMPOSITIONS FOR MANUFACTURING POLYNUCLEOTIDES | PRIMORDIAL GENETICS INC. | 2023-03-09 | — | — | US | disclosed |
| WO-2022233255-A1 | PREPARATION AND COMPOSITION OF NOVEL 4(3H)-QUINAZOLINONE ANALOGUE/CYCLIC DINUCLEOTIDE CGAMP CO-LOADED LIPOSOME AND APPLICATION THEREOF IN ANTITUMOR DRUGS | 杭州星鳌生物科技有限公司 | 2022-11-10 | — | — | WO | disclosed |
| CN-110093284-A | Method for improving protein synthesis efficiency in cell | 康码（上海）生物科技有限公司 | 2019-08-06 | — | — | CN | disclosed |
| CN-109971783-A | In-vitro protein synthesis system, kit and preparation method thereof | 康码（上海）生物科技有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-108949801-B | A method of by knocking out nucleic acid enzyme system to regulate and control external biological synthesizing activity | 康码（上海）生物科技有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109837293-A | A kind of series connection DNA element that can enhance protein synthesis efficiency | 康码（上海）生物科技有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109071618-A | MUTANT PORE | 牛津纳米孔技术公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-108398397-A | Detection system of nucleoside triphosphate compound and application thereof | 中国科学院理化技术研究所 | 2018-08-14 | — | — | CN | disclosed |
| CN-101557726-A | High-potency sweetener composition with Rubisco protein, Rubiscolin, Rubiscolin derivatives, ACE inhibitory peptides, and combinations thereof, and compositions sweetened therewith | COCA COLA CO (US) | 2009-10-14 | — | — | CN | disclosed |
| CN-101553132-A | High-potency sweetener compositions with phytoestrogens and compositions sweetened therewith | COCA COLA CO (US) | 2009-10-07 | — | — | CN | disclosed |
| CN-101365348-A | High-potency sweetener composition with vitamin and compositions sweetened therewith | COCA COLA CO (US) | 2009-02-11 | — | — | CN | disclosed |
| CN-101340826-A | High-potency sweetener composition with fatty acid and compositions sweetened therewith | COCA COLA CO (US) | 2009-01-07 | — | — | CN | disclosed |
| CN-101309601-A | High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith | COCA COLA CO (US) | 2008-11-19 | — | — | CN | disclosed |
| CN-101309598-A | Calcium-containing high-potency sweetener composition and compositions sweetened therewith | COCA COLA CO (US) | 2008-11-19 | — | — | CN | disclosed |
| CN-101000348-A | Method of GTP combining experimental signal window of enlarging GPCR tagging | SHANGHAI TARGET MEDICINE CO LT (CN) | 2007-07-18 | — | — | CN | disclosed |
| WO-2006003638-A2 | NOVEL METHOD FOR LABELING NUCLEIC ACID IN A SEQUENCE-SPECIFIC MANNER, AND METHOD FOR DETECTING NUCLEIC ACID USING THE SAME | NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES (JP) | 2006-01-12 | — | — | WO | disclosed |
| US-6453064-B1 | Common structure extraction apparatus | FUJITSU LIMITED (JP) | 2002-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600958-B2 | Methods and compositions for manufacturing polynucleotides | MED25, RNGTT, NSUN2 | NT5E 132/4885TGM2 1375/4885HPGD 3276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.